Abstract
Brain tumours and their associated treatments can lead to progressive impairments of communication, adversely affecting quality-of-life. This commentary explores our concerns that people with speech, language, and communication needs face barriers to representation and inclusion in brain tumour research; we then offer possible solutions to support their participation. Our main concerns are that there is currently poor recognition of the nature of communication difficulties following brain tumours, limited focus on the psychosocial impact, and lack of transparency on why people with speech, language, and communication needs were excluded from research or how they were supported to take part. We propose solutions focusing on working towards more accurate reporting of symptoms and the impact of impairment, using innovative qualitative methods to collect data on the lived experiences of speech, language, and communication needs, and empowering speech and language therapists to become part of research teams as experts and advocates for this population. These solutions would support the accurate representation and inclusion of people with communication needs after brain tumour in research, allowing healthcare professionals to learn more about their priorities and needs.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
In 2020, an estimated 308,100 primary malignant brain tumours were diagnosed worldwide [1]. A brain tumour and the treatment thereof, can lead to progressive impairment of communication, adversely affecting interactions with others and multiple aspects of quality-of-life (QoL) [2]. Cancer survivorship research seeks to understand the experiences and impacts of cancer to inform the need for services and/or development of interventions. This commentary outlines our concerns regarding the representation and inclusion of brain tumour patients with speech, language, and communication needs (SLCN) in such research and based on our expertise, proposes ways forward.
Concerns
Poor recognition of the nature of SLCN following brain tumour
Speech, language, and communication impairments following brain tumours may progress slowly and be difficult to detect [3], meaning it can be challenging to capture their impact. Cognitive difficulties may also impair communication. While formal assessment is more likely to demonstrate difficulties than self-report [4], some language assessments lack sensitivity and specificity [3, 5]. People with brain injury may also have limited insight into their difficulties [6]. Despite this, scale measures frequently contain broad terms such as ‘difficulty speaking’ or ‘word finding difficulties’, which are insensitive to the precise nature of impairment. For those with more severe SLCN, researchers often rely on carer report, which may not be an accurate proxy measure [7].
Limited understanding of the psychosocial impact
While survivorship studies on brain tumours are relatively uncommon, there is a growing focus on QoL outcomes. Within quantitative studies, communication-related measures are infrequently used [8]. Some more broadly focused qualitative studies provide a glimpse into the impact of SLCN. For example, concerns about speech [9], lack of awareness and insight [10], or the adaptations needed by carers to support communication [11, 12]. Across both qualitative and quantitative research, those with more severe language and literacy impairments may be daunted to take part or experience considerable barriers.
Transparency around inclusion in research
Participation in research can be demanding of both communication and cognitive skills, and potential participants are commonly excluded due to reasons such as ‘unable to communicate adequately’, or ‘do not understand due to cognitive or language impairment’. In such situations, it is important to question whether excluded participants with SLCN could be facilitated to understand the nature of a study, to consent, or to participate, and whether included participants have been provided with all the help they need. Such provision can be viewed alongside relevant legislation, such as the Mental Capacity Act (2005) in the UK [13]. In the field of stroke, there have also been calls for better inclusion [14]; researchers have reported they lack tools and support to determine capacity and obtain consent when working with neurologically impaired people [15]. It is possible these same barriers exist for those working with brain tumour populations.
Failure to represent this population adequately results in a lack of evidence to support appropriate interventions towards improving functioning and QoL. There are three main areas where we believe that improvements could be made:
Solutions
Work towards improving accuracy of reporting of impairment
Improved understanding of differences in the range of SLCN after a brain tumour, and more appropriate use of terminology, would be of value. Figure 1 aims to support this by summarising SLCN in adult neurological populations, illustrating how speech, language, and communication are both distinct and closely related. Communication difficulties stemming from speech impairment can be solely related to impaired musculature/motor functioning (dysarthria) or to motor planning (apraxia of speech). These impairments can exist in isolation but may also occur alongside acquired impairment of understanding or production of language (aphasia). There are a broad range of ‘cognitive communication disorders’ where higher level functioning interacts with and influences various aspects of communication such as memory, attention, or social use of language. These types of difficulties can result in features such as repetitive questions, or difficulties staying on topic and in delivering responses at the right time in conversations. Whether speech, language, or communication is impaired (individually or in combination) following a brain tumour, each manifestation will have different consequences and be impacted by personal (e.g., mood/emotional status, resilience, or experience of frustration) or external factors (e.g., support systems, treatment-related fatigue).
Explore innovative ways to engage with seldom-heard voices
For many who would struggle to take part in large-scale quantitative studies, methodologically rigorous qualitative research offers possibilities for inclusion [16]. There are some examples of this nature in dementia and aphasia research e.g. [17, 18]. Although conventional methods may be challenging (e.g., open questions), data can be collected in creative ways. Experienced facilitators can explore means to convey messages via alternative strategies (e.g., drawing or gesture); ethnography can observe everyday interactions; and conversation analysis can identify sources of communication breakdown. Anyone interested in supporting communication can complete conversation partner training (e.g., the free online course provided by Communication Access UK; https://communication-access.co.uk/). Evidence from aphasia research suggests that improving interactions this way successfully reduces risk of negative psychosocial consequences [19].
Include and empower speech and language therapists across research
Including speech and language therapists (SLTs) in study teams could support meaningful inclusion in both qualitative and quantitative research. They can advise on alternative and augmentative communication methods, create and facilitate use of accessible study documentation, support mental capacity assessment and the consent process, conduct interviews, and improve accuracy when writing up results. Brain tumour research(ers) can learn from work led and influenced by SLTs, e.g., with populations that present similar challenges [20], while the SLT profession could become more involved as advocates for a vulnerable population.
Discussion of the concerns outlined above and of our suggested ways forward could improve research quality and depth of understanding of the impact of brain tumours on speech, language and communication and QOL. By working together, researchers and clinicians can speak up for the lost voices and generate the evidence to inform the development of services and supports to better meet the needs of those affected by SCLN following a brain tumour.
References
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660
Rimmer B, Bolnykh I, Dutton L et al (2022) Health-related quality of life in adults with low-grade gliomas: a systematic review. Qual Life Res. https://doi.org/10.1007/s11136-022-03207-x
Brownsett SL, Ramajoo K, Copland D, McMahon KL, Robinson G, Drummond K, Jeffree RL, Olson S, Ong B, De Zubicaray G (2019) Language deficits following dominant hemisphere tumour resection are significantly underestimated by syndrome-based aphasia assessments. Aphasiology 33(10):1163–1181. https://doi.org/10.1080/02687038.2019.1614760
Antonsson M, Longoni F, Jakola A, Tisell M, Thordstein M, Hartelius L (2018) Pre-operative language ability in patients with presumed low-grade glioma. J Neurooncol 137(1):93–102. https://doi.org/10.1007/s11060-017-2699-y
Papatzalas C, Fountas K, Kapsalaki E, Papathanasiou I (2021) The use of standardized intraoperative language tests in awake craniotomies: a scoping review. Neuropsychol Rev 31:1–31. https://doi.org/10.1007/s11065-021-09492-6
Ediebah DE, Quinten C, Coens C, Ringash J, Dancey J, Zikos E, Gotay C, Brundage M, Tu D, Flechtner HH, Greimel E (2018) Quality of life as a prognostic indicator of survival: a pooled analysis of individual patient data from Canadian cancer trials group clinical trials. Cancer 124(16):3409–3416. https://doi.org/10.1002/cncr.31556
Cruice M, Worrall L, Hickson L, Murison R (2005) Measuring quality of life: comparing family members’ and friends’ ratings with those of their aphasic partners. Aphasiology 19(2):111–129. https://doi.org/10.1080/02687030444000651
Neumann S, Quinting J, Rosenkranz A, De Beer C, Jonas K, Stenneken P (2019) Quality of life in adults with neurogenic speech-language-communication difficulties: a systematic review of existing measures. J Commun Disord 79:24–46. https://doi.org/10.1016/j.jcomdis.2019.01.003
Halkett GK, Lobb EA, Oldham L, Nowak AK (2010) The information and support needs of patients diagnosed with high grade glioma. Patient Educ Couns 79(1):112–119. https://doi.org/10.1016/j.pec.2009.08.013
Langbecker D, Ekberg S, Yates P (2017) Don’t need help, don’t want help, can’t get help: How patients with brain tumors account for not using rehabilitation, psychosocial and community services. Patient Educ Couns 100(9):1744–1750. https://doi.org/10.1016/j.pec.2017.04.004
Sterckx W, Coolbrandt A, Clement P, Borgenon S, Decruyenaere M, De Vleeschouwer S, Mees A, de Casterlé BD (2015) Living with a high-grade glioma: a qualitative study of patients’ experiences and care needs. Eur J Oncol Nurs 19(4):383–390. https://doi.org/10.1016/j.ejon.2015.01.003
Schubart JR, Kinzie MB, Farace E (2008) Caring for the brain tumor patient: family caregiver burden and unmet needs. Neuro Oncol 10(1):61–72. https://doi.org/10.1215/15228517-2007-040
Jayes M, Palmer R, Enderby P (2022) Evaluation of the MCAST, a multidisciplinary toolkit to improve mental capacity assessment. Disabil Rehabil 44(2):323–330. https://doi.org/10.1080/09638288.2020.1765030
Brady MC, Fredrick A, Williams B (2013) People with aphasia: capacity to consent, research participation and intervention inequalities. Int J Stroke 8(3):193–196. https://doi.org/10.1111/j.1747-4949.2012.00900
Jayes MJ, Palmer RL (2014) Stroke research staff’s experiences of seeking consent from people with communication difficulties: results of a national online survey. Top Stroke Rehabil 21(5):443–451. https://doi.org/10.1310/tsr2105-443
Hersh D, Azul D, Carroll C, Lyons R, Mc Menamin R, Skeat J (2022) New perspectives, theory, method, and practice: qualitative research and innovation in speech-language pathology. Int J Speech Lang Pathol 22:1–1. https://doi.org/10.1080/17549507.2022.2029942
Kindell J, Sage K, Wilkinson R, Keady J (2014) Living with semantic dementia: a case study of one family’s experience. Qual Health Res 24(3):401–411. https://doi.org/10.1177/1049732314521900
Parr S (2007) Living with severe aphasia: tracking social exclusion. Aphasiology 21(1):98–123. https://doi.org/10.1080/02687030600798337
Baker C, Worrall L, Rose M, Hudson K, Ryan B, O’Byrne L (2018) A systematic review of rehabilitation interventions to prevent and treat depression in post-stroke aphasia. Disabil Rehabil 40(16):1870–1892
Volkmer A, Spector A, Beeke S (2018) Better conversations with primary progressive aphasia (BCPPA): asking people with PPA and their families how speech and language therapists could support them to live well and maintain relationships. Aphasiology 32(sup1):239–240. https://doi.org/10.1080/02687038.2018.1486373
Acknowledgements
Thanks to Janet Webster and Ben Rimmer for their support with this paper.
Funding
This commentary was stimulated by discussions arising from the Ways Ahead Project, funded by the Brain Tumour Charity (GN-000435). Harriet Mandley’s initial work was funded by an internal Newcastle University Covid impact research grant awarded to Fiona Menger. Anna Volkmer is funded by an NIHR Advanced Fellowship (NIHR302240).
Author information
Authors and Affiliations
Contributions
Fiona Menger wrote the first draft and post-review drafts of the manuscript based on research internship work conducted by Harriet Mandley. All authors commented on previous versions. Linda Sharp and Anna Volkmer contributed equally as final author. Joanne Lewis reviewed drafts and contributed to discussions on the paper. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Anna Volkmer and Linda Sharp contributed equally as final authors.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Menger, F., Cresswell, H., Lewis, J. et al. Speaking up for the lost voices: representation and inclusion of people with communication impairment in brain tumour research. Support Care Cancer 31, 355 (2023). https://doi.org/10.1007/s00520-023-07804-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00520-023-07804-5